Oral Dose Of Remdesivir To Soon Hit Markets: Research
Gilead Sciences, the developers of Remdesivir, promising treatment against Covid-19, created a modified version of the medicine. The company, as per reports, has partnered with researchers at Georgia State University, where they have found the medicine to be highly effective in surpassing SARS-CoV-2 replication and transmission in animals when given orally. "It would be groundbreaking in improving patient access to treatment early after… read-more
Tags: covid 19, Noval corona virus, SARs-CoV-2 virus, Georgia university, REMDESIVIR
Courtesy: The Indian Express
SARS-CoV-2 Transmitted From Animals, Says US Intelligence
A report published by the US Director of National Intelligence revealed on August 27 with low confidence, the SARS-CoV-2 virus was transmitted from an animal. The report was concluded with scarcity of information as President Biden continues to protest against China's lack of cooperation. But the report believes Chinese leaders were oblivious about the virus before the pandemic happened. However, the research members still remain divided on… read-more
Tags: Director of National Intelligence, SARs-CoV-2 virus, President Biden, China
Courtesy: Wion News
COVID-19 Third Wave May Hit Its Peak Btw Oct-Nov: Govt Panel
According to a scientist from the COVID-19 government panel, an alleged third wave of Covid-19 may strike between October-November. However, India is likely to witness half of the cases recorded daily during the second surge. The infection can spread rapidly if a new mutant of SARS-CoV-2 is found. Earlier, last year the Department of Science and Technology had formed the panel to tackle coronavirus cases surge using mathematical models.
Tags: Covid-19, Scientist, Manindra Agarwal, SARs-CoV-2 virus, COVID-19 government panel
Courtesy: The Indian Express
Union Govt Claims Covishield, Covaxin Effective Against SARS-CoV-2
The Union Government has addressed that 'Covishield' produced by Serum Institute, and 'Covaxin' by Bharat Biotech is assumed to be effective against SARS-CoV-2 variants Delta, Alpha and Gamma. However, the efficacy test is still under process and results will be out within the next week. As per the ICMR Director General, Balram Bhargava, Covishield reduces its efficiency by 2.5 times with Alpha while Covaxin is potent with Delta.
Tags: Covid-19, SARs-CoV-2 virus, COVISHIELD, Covaxin, Covid-19 Vaccine
Courtesy: Times Now Digital
Maharastra Reports Seven Cases Of SARS-CoV-2 Delta-Plus Variant
With just seven positive cases for the Delta-plus SARS-CoV-2 variant in Maharashtra, it is safely classified as "a variant of interest" and not "a variant of concern". Though Delta-plus has a "better immune-escaping mechanism", research is on to check the virus' transmissibility, virulence and resistance to monoclonal antibody cocktail treatment. Unlike the Delta variant where entire families came positive, it has been found only in Ratnagiri… read-more
Tags: SARs-CoV-2 virus, Maharashtra , Delta-plus variant, Ratnagiri, Navi Mumbai, Palghar
Courtesy: The Indian Express
Indian Doctors Prescribing Ivermectin Despite WHO Advice Against Its Use
Despite WHO’s advice to avoid consumption of anti-parasite drug Ivermectin, the drug is rampantly used in India by mild COVID-19 patients under home isolation. The orally administered drug is recommended in India’s revised national COVID-19 treatment protocol. Interestingly, the drug maker also clarified of no evidence of its efficacy against coronavirus. Meanwhile, Indian physicians suggesting Ivermectin, claimed that the drug has shown to… read-more
Tags: ivermectin, drug, Covid-19, COVID-19 DRUG, WHO, SARs-CoV-2 virus, Uttarakhand, Goa, Karnataka
Courtesy: The Hindu
Karnataka Reports Its First South African Variant COVID-19 Case
South Africa variant 501.V2 of the COVID-19 has now been reported in Karnataka on March 10. Reportedly, the 58-year-old patient, who traveled from Dubai to Bengaluru on February 22. is now under quarantine along with his 8 contacts. Health Commissioner Dr Trilok Chandra said the patient and his contacts are from Shivamogga and all of them are asymptomatic. West Bengal, Surat (Gujarat), and Maharashtra have also reported COVID-19 patients with… read-more
Tags: Covid-19, SARs-CoV-2 virus, South Africa, HOME QURANTINED
Courtesy: Deccan Herald
Oldest Vaccine for Tuberculosis Reduce the Risk of Contracting COVID-19
As per a new study, Bacillus Calmette-Guerin (BCG) - the oldest vaccine for Tuberculosis - is likely to reduce the risk of contracting COVID-19. The researchers have tested the blood of more than 6,000 healthcare workers for the antibodies against SARS-CoV-2. In which, 30% of the workers, who have received BCG vaccinations in the past, were likely to test negative for the virus. However, the reason is still ambiguous.
Tags: Covid-19, SARs-CoV-2 virus, health care, vaccine
Courtesy: Financial Express
Study Reveals Lab Developed Lungs Damaged When Infected with SARS-CoV-2
Scientists from South-Korea and United-Kingdom developed lungs from the stem cells and infected them with SARS-CoV-2 to study its impact. It was found in both the studies that the virus damages the alveoli air-sacs containing oxygen and carbon-di-oxide, which causes pneumonia and respiratory problems leading to fatality in major cases. Initially, the cells produced protein as warning signals to neighbouring cells and showed resistance, after… read-more
Tags: Coronavirus, Covid-19, SARs-CoV-2 virus, uk scientists, South Korea, Stem cells
Courtesy: Indian Express
Scientists Explore Neurological Repercussions of COVID-19
Australian Neuroscientists are exploring the possible connection between COVID-19 and the increased threat of Parkinson's disease, in order to find a cure for the virus. The scientists have termed the consequences of COVID-19 as a 'silent wave' and have asked for immediate action to make available accurate diagnostic tools. These tools will help to identify neurodegeneration and will provide long-term care to people who have been affected by… read-more
Tags: Scientist, Covid-19, Diagnostics, SARs-CoV-2 virus
Courtesy: ANI News